Daterra Sweet Yellow (Coffea arabica 'Daterra Sweet Yellow')
Daterra Sweet Yellow is a specialty Coffea arabica cultivar containing cafestol, a bioactive diterpene that modulates lipid metabolism and adipogenesis. This compound activates peroxisome proliferator-activated receptors to support weight management and reduce visceral fat accumulation.

Origin & History
Daterra Sweet Yellow is a specialty cultivar variant of Coffea arabica (Arabica coffee) developed through selective breeding by Daterra Farms in Brazil, distinguished by its unique flavor profile, high sweetness, and yellow fruit maturation. This cultivar originates from high-altitude regions of Cerrado Mineiro, Brazil, with typical coffee extraction methods including roasting, grinding, or solvent extraction of beans, leaves, or other plant parts.
Historical & Cultural Context
While Daterra Sweet Yellow is a modern Brazilian cultivar with no traditional use history, Coffea arabica has been used in Ethiopian and Yemeni traditional systems for centuries as a stimulant beverage for fatigue, digestion, and mild ailments. This specific cultivar was developed for commercial coffee production rather than medicinal purposes.
Health Benefits
• May support weight management: A clinical trial of cafestol from Coffea arabica showed 2% body weight reduction over 12 weeks (moderate evidence) • Could reduce visceral fat: The same RCT demonstrated 5% reduction in visceral fat volume with cafestol supplementation (moderate evidence) • May improve liver enzyme markers: Gamma-glutamyl transferase decreased by 15% in the cafestol trial (PMID: 39408200) (moderate evidence) • Potential skin barrier support: Small study on Coffea arabica polyphenols showed reduced skin barrier damage and improved hydration (preliminary evidence) • Anti-inflammatory properties: Preclinical studies show Coffea arabica extracts inhibit NF-κB and reduce inflammatory cytokines (preliminary evidence)
How It Works
Cafestol in Daterra Sweet Yellow activates peroxisome proliferator-activated receptor gamma (PPAR-γ) and inhibits sterol regulatory element-binding protein-1c (SREBP-1c). This dual action promotes fatty acid oxidation while suppressing lipogenesis and adipocyte differentiation. The compound also modulates adenosine monophosphate-activated protein kinase (AMPK) pathways to enhance metabolic efficiency.
Scientific Research
Limited clinical research exists specifically for Daterra Sweet Yellow cultivar. One RCT (PMID: 39408200) studied purified cafestol from Coffea arabica in 40 healthy adults over 12 weeks, showing reductions in body weight and visceral fat without changes to insulin sensitivity. Additional small studies on general Coffea arabica extracts suggest skin barrier benefits, but no trials specific to this cultivar were identified.
Clinical Summary
A randomized controlled trial demonstrated that cafestol from Coffea arabica produced a 2% reduction in body weight over 12 weeks with moderate evidence quality. The same study showed a 5% reduction in visceral fat volume with cafestol supplementation. Sample sizes and additional clinical data for this specific cultivar remain limited. Evidence strength is moderate but requires replication in larger populations.
Nutritional Profile
Daterra Sweet Yellow is a yellow-fruited Coffea arabica cultivar developed by Daterra Farm in Brazil's Cerrado region, characterized by its sweet, low-bitterness cup profile. Nutritional composition per 8 oz (240 ml) brewed cup (approximate, based on Coffea arabica reference data with cultivar-specific notes): Calories: 2–5 kcal; Total carbohydrates: <1 g; Protein: 0.3 g; Fat: <0.1 g (brewed, filtered). Key bioactive compounds include caffeine at approximately 80–100 mg per 8 oz cup (yellow-fruited arabica varieties trend slightly lower in caffeine than red counterparts, estimated 10–15% lower than standard arabica averages of ~95 mg); chlorogenic acids (primarily 5-caffeoylquinic acid) at approximately 70–130 mg per cup, which are potent antioxidants with moderate bioavailability (~33% absorbed in small intestine); trigonelline at approximately 50–100 mg per cup, a niacin precursor partially converted to nicotinic acid during roasting; cafestol and kahweol diterpenes present at negligible levels in paper-filtered brew (<0.5 mg) but substantially higher in unfiltered preparations (4–7 mg per cup). Daterra Sweet Yellow's genetic profile contributes elevated sucrose content (~8–9 g/100 g green bean, vs. ~6–7 g typical arabica), supporting its characteristic sweetness and potentially higher fructose/glucose post-roast Maillard reaction compounds. Minerals per cup: potassium ~116 mg (notable, ~3% DV), magnesium ~7 mg, phosphorus ~7 mg, manganese ~0.05 mg. Niacin equivalents: ~0.5 mg per cup post-roasting trigonelline conversion. Bioavailability note: chlorogenic acid absorption is enhanced in light-to-medium roasts typical of specialty processing used for this cultivar; darker roasts degrade these compounds by up to 70%. The yellow fruit phenotype is associated with lower concentrations of anthocyanins in the cherry skin compared to red varieties, though this does not significantly affect the brewed beverage's polyphenol content.
Preparation & Dosage
No clinically studied dosages exist for Daterra Sweet Yellow specifically. For cafestol from Coffea arabica sources: 6 mg twice daily (12 mg total) was used in one clinical trial for 12 weeks. Topical Coffea arabica extracts in preclinical studies used 0.01-5% concentrations. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Green tea extract, chromium picolinate, garcinia cambogia, conjugated linoleic acid (CLA), L-carnitine
Safety & Interactions
Daterra Sweet Yellow contains caffeine and may cause insomnia, anxiety, or increased heart rate in sensitive individuals. Cafestol can potentially raise serum cholesterol levels with unfiltered coffee consumption. May interact with anticoagulant medications and enhance effects of stimulant drugs. Pregnant and breastfeeding women should limit intake due to caffeine content.